Revised criteria for the diagnosis and staging of Alzheimer’s disease
Mayo Clinic · Mayo Clinic in Arizona · +23 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
157
total citations
- FWCI
- 52.96
- Percentile
- 100%
- References
- 14
Citations per year
Authors
20Topics & keywords
Topics
Keywords
- Disease
- Alzheimer's disease
- Medicine
- Intensive care medicine
- Pathology
No related works found for this paper.
Funding
- BABill and Melinda Gates Foundation
- AAAlzheimer's Association
- ALAbbott Laboratories
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- SSanofi
- BABrigham and Women's Hospital
- BBiogen
- UOUniversity of Southern California
- BFBrightFocus Foundation
- APAlnylam Pharmaceuticals
- CCelgene
- UOUniversity of Miami
- IUIndiana University-Purdue University Indianapolis
- UDUniversità Degli Studi di Modena e Reggio Emila
- EJEU Joint Programme – Neurodegenerative Disease Research
- APACADIA Pharmaceuticals
- PProthena
- GFGHR Foundation
- HHealth~HollandAward: LSHM20106
- DTDenali Therapeutics
- IPInternational Progressive MS Alliance
- LFLouLou Foundation
- CTCerveau Technologies
- AUAmsterdam University Medical Centers
- ECEuropean CommissionAwards: 101034344, 831434, 860197
- ZZonMwAwards: 10510032120003, 73305095007
- NONederlandse Organisatie voor Wetenschappelijk OnderzoekAward: 73305095007
- LULunds Universitet
- EEisai
- NNNovo Nordisk
- SShionogi
- ANAlzheimer NederlandAward: LSHM20106
- HLH. Lundbeck A/S
- GGrifols
- NINational Institutes of HealthAwards: U19AG078109, U19AG073153, R01AG062167, RF1AG052324, R01AG066203, U19AG024904, R01AG077507, R01AG070028, R01AG027161
- UFU.S. Food and Drug Administration
- GGenentech
- FBFidelity Biosciences
- NPNovartis Pharma
- ARAvid Radiopharmaceuticals
- UHUniversitätsklinikum Hamburg-Eppendorf
- NINational Institute on AgingAwards: R01AG070028, U19AG073153, RF1AG052324, U19AG078109, R01AG066203, R01AG062167, U19AG024904, R01AG027161, R01AG077507